AbbVie's premium bid for Allergan isn't enough for one investor, who's suing to block it

23rd September 2019 Uncategorised 0

Allergan encountered years of setbacks before AbbVie swooped in this summer to purchase the company for a whopping $63 billion. But one unhappy Allergan investor’s trying to block the deal with a class-action lawsuit citing executive payouts, withheld information and more.

More: AbbVie's premium bid for Allergan isn't enough for one investor, who's suing to block it
Source: fierce